Welcome to NewPressRelease.com a free press release service. Publishing press releases for Public Relations never been easier. Just register (it's free and it takes less then a 1 minute) then use Submit Press Release. Our services aim to help you reach journalists and to improve visibility in search engine listings, so you can get the most publicity possible.

Everist Genomics Revolutionizes the Field of Genomics with Their Range of Products

Health and Fitness

(Free Press Release) As a privately owned genomics company based in Ann Arbor, Michigan, Everist Genomics designs advanced products that can improve the treatment outcome for a wide range of severe medical conditions including cancer.

Everist Genomics Revolutionizes the Field of Genomics with Their Range of Products


      

As a privately owned genomics company based in Ann Arbor, Michigan, Everist Genomics designs advanced products that can improve the treatment outcome for a wide range of severe medical conditions including cancer, cardiovascular disease, neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease, and diabetes. They are committed to their research and they have even teamed up with academic institutions such as The University of Michigan School of Public Health, Sanford Health’s BioBank, The University of Michigan's Department of Pathology, The University of Southern California Department of Pathology, Mayo Validation Support Services, and The Netherlands Organization for Applied Scientific Research in order to collaborate and product better output.

The company does research with established doctors in the field of oncology and diagnostics testing such as Professor Stephen B. Gruber (M.D., Ph.D., and M.P.H.). The company’s main growth drivers are proprietary research and development, in-licensing, innovative prognostics, and targeted acquisitions. Through this business model the company is able to successfully develop advanced technology such as the proprietary Evolver platform that helps accelerate the launch times of innovative molecular prognostic tests.

The company recently made headlines for their colorectal cancer prognostic test OncoDefender™-CRC that guides medical practitioners and cancer specialists make important and critical decisions regarding the treatment process for Stage I rectal cancer and Stage I/II colon cancer after surgery. Another success story is AngioDefender which is a result of their majority interest in Angiologix Inc.. This is a testing device that scores over other commercially available cardiovascular screening tools by detecting early damage to endothelial cells even in asymptomatic patients who have normal blood pressure and cholesterol levels. This helps doctors accelerate the treatments process for at-risk patients. Additionally the company has a program wherein patients with no insurance can avail of a variety of financial assistance programs for up to 80% of diagnostic testing fees, patients can visit Everistgenomics.com for more information.




Everist Genomics Revolutionizes the Field of Genomics with Their Range of Products

Source: Press Release

---------------------------

Disclaimer

If you have any questions regarding information in this press release, please contact the person listed as the Author or use the contact informations published in the press release. Please do not attempt to contact NewPressRelease.com. We are unable to assist you with any information regarding this release. NewPressRelease.com disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.

All press release information on this site, including free press releases, is solely based on what our users submit. NewPressRelease.com disclaims that any right and responsibility for the information goes to the user who submit the press release. Some press release may be confusing without additional explanation. You should contact the provider with any questions about the information presented. In case some press release damages your benefits or violate your rights in any way, please contact us and we'll remove it immediately.


Copyright © 2008 - 2018 Free Press Release by NewPressRelease.com